Thrombosis and Coagulopathy
Review published in Neurosurgery clinics of North America (2025)
Abstract
Effective anticoagulation management is crucial for balancing thromboembolism and hemorrhage risks in patients with traumatic brain injury (TBI) and spinal cord injury (SCI). A systematic review from January 1984 to August 2024 highlights a growing preference for prothrombin complex concentrate (PCC) as the primary reversal agent, with limited evidence on idarucizumab for dabigatran. Most studies show that 4F-PCC improves mortality and hemostatic efficacy, facilitating faster surgical interventions. The lack of large clinical trials remains a significant gap, limiting the development of standardized protocols. Increasing use of viscoelastic assays for assessing residual anticoagulant activity offers potential for more personalized treatment strategies.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Effective anticoagulation management is crucial for balancing thromboembolism and hemorrhage risks in patients with traumatic brain injury (TBI) and spinal cord injury (SCI).
Por qué esto importa para la hirudoterapia
This systematic review (January 1984–August 2024) examined anticoagulation management in traumatic brain injury and spinal cord injury, finding a growing preference for 4F-prothrombin complex concentrate as the primary reversal agent, limited evidence on idarucizumab for dabigatran, and increasing use of viscoelastic assays for assessing residual anticoagulant activity. The abstract does not mention leeches, hirudotherapy, hirudin, or any leech-derived compounds at any point. The review's focus is entirely on pharmacological anticoagulation reversal strategies in trauma patients, and there is no defensible connection to ASH's domain of hirudotherapy or the leech secretome based on this abstract.
Citación
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026